These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29929002)

  • 1. HIV pre-exposure prophylaxis (PrEP): Is it time to rethink HIV prevention in travelers?
    Hampel B; Reinacher M; Fehr JS
    Travel Med Infect Dis; 2018; 25():6-7. PubMed ID: 29929002
    [No Abstract]   [Full Text] [Related]  

  • 2. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study.
    Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Walach C; Placido T; Bogoch II
    AIDS Patient Care STDS; 2015 Aug; 29(8):431-6. PubMed ID: 26154174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
    Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.
    Yoong D; Naccarato M; Sharma M; Wilton J; Senn H; Tan DH
    Int J STD AIDS; 2016 Jul; 27(8):608-16. PubMed ID: 26025254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention Strategies Against HIV Transmission: A Proactive Approach.
    Carrion AJ; Miles JD; Mosley JF; Smith LL; Prather AS; Gurley MM; Phan LD; Everton EC
    J Pharm Pract; 2018 Feb; 31(1):82-90. PubMed ID: 29278971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe.
    Coleman R; Prins M
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067904
    [No Abstract]   [Full Text] [Related]  

  • 8. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
    Tan DHS; Hull MW; Yoong D; Tremblay C; O'Byrne P; Thomas R; Kille J; Baril JG; Cox J; Giguere P; Harris M; Hughes C; MacPherson P; O'Donnell S; Reimer J; Singh A; Barrett L; Bogoch I; Jollimore J; Lambert G; Lebouche B; Metz G; Rogers T; Shafran S;
    CMAJ; 2017 Nov; 189(47):E1448-E1458. PubMed ID: 29180384
    [No Abstract]   [Full Text] [Related]  

  • 9. Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12.
    Christiansen AH; Rodriguez AB; Nielsen J; Cowan SA
    J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27147729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Ă–zdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.
    Lykins WR; Luecke E; Johengen D; van der Straten A; Desai TA
    Drug Deliv Transl Res; 2017 Dec; 7(6):805-816. PubMed ID: 28612340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV Pre-Exposure prophylaxis (PrEP) in men].
    Spinner CD
    MMW Fortschr Med; 2017 Jun; 159(Suppl 2):40-42. PubMed ID: 28597265
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.
    Nikolopoulos GK; Christaki E; Paraskevis D; Bonovas S
    Curr Pharm Des; 2017; 23(18):2579-2591. PubMed ID: 28356043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis.
    Holt M
    Cult Health Sex; 2015; 17(4):428-39. PubMed ID: 25270549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
    Venter F; Allais L; Richter M
    Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure prophylaxis (PrEP) for people who inject drugs: reconciling community views and biomedical advances.
    Guise A; Albers ER; Strathdee SA
    Addiction; 2017 Apr; 112(4):584-585. PubMed ID: 28181334
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
    Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
    Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
    Herron PD
    LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FACTS about women and pre-exposure prophylaxis.
    Seidman D; Weber S; Aaron E; Cohan D; Grant R
    Lancet HIV; 2015 Jun; 2(6):e228. PubMed ID: 26423194
    [No Abstract]   [Full Text] [Related]  

  • 20. Using data from a behavioural survey of men who have sex with men (MSM) to estimate the number likely to present for HIV pre-exposure prophylaxis (PrEP) in Ireland, 2017.
    Nic Lochlainn L; O'Donnell K; Hurley C; Lyons F; Igoe D
    Euro Surveill; 2017 Nov; 22(48):. PubMed ID: 29208157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.